iboxamycin
Iboxamycin is a fully synthetic lincosamide antibiotic. Like other lincosamides, it selectively targets the bacterial ribosome and prevents elongation of the peptide chain. Iboxamycin has been shown to be effective against bacterial strains otherwise resistant to licosamide antibiotics.
Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.
Classification
lincosamide antibioticARO:0000017
- lincosamide antibiotic
ARO:0000017
Chemical structure
| Molecular formula | C22H39ClN2O6S |
|---|---|
| Charge | 0 |
| Average mass | 495.1 Da |
| Monoisotopic mass | 494.2217358 Da |
| Source | PubChem · retrieved 2026-08-29 |
| InChIKey | JPCLUJPDWMBCAA-SUTQZAMLSA-N |
C[C@@H]([C@H]([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)SC)O)O)O)NC(=O)[C@@H]2[C@H]3[C@@H](C[C@@H](CCO3)CC(C)C)CN2)Cl
InChI=1S/C22H39ClN2O6S/c1-10(2)7-12-5-6-30-19-13(8-12)9-24-15(19)21(29)25-14(11(3)23)20-17(27)16(26)18(28)22(31-20)32-4/h10-20,22,24,26-28H,5-9H2,1-4H3,(H,25,29)/t11-,12-,13-,14+,15-,16-,17+,18+,19+,20+,22+/m0/s1
Cross-references
- iboxamycin
ARO:3007636 - pubchem.compound:156613433
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| ARO | ARO:3007636 |
iboxamycin | antibioticmech:aro-6d3a6e6b69 |
2026-08-30 |
Resistance mechanisms
ANTIBIOTIC_TARGET_PROTECTION 5
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| Clostridioides difficile cplR | ARO:3007637 | — | ||
| Clostridium perfringes cplR | ARO:3007644 | — | ||
| Clostridium sporogenes cplR | ARO:3007645 | — | ||
| Neobacillus vireti vmlR2 | ARO:3007646 | — | ||
| vmlR | ARO:3004476 | — |
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (ARO)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories